Tri Maharani



Maharani_Tri

Stigma and Survivor Covid-19

Dr Tri Maharani was awarded her Bachelor and PhD from the University of Brawijaya and received her Masters (majoring in immunology) from the University of Airlangga. She currently works at the Daha Husada hospital, Kediri, East Java and has worked at Department of Emergency Medicine, Faculty of Medicine, University of Brawijaya and the Saiful Anwar General Hospital in Malang, East Java. Dr Maha is a member of Lapor Covid.

Stigma and Survivor Covid-19

There are an increasing number of cases of Covid-19 in Indonesia, and the rate of infection is high. Screening and diagnosis are a serious problem throughout Indonesia. The difficult conditions mean that there is poor management of, and treatment for, many Covid-19 patients in Indonesia. People must not only survive the virus but also the stigma, which commences at the point of receiving a positive diagnosis until their recovery.  As a result of the stigma, many Covid-19 patients also suffer psychiatric problems. Health workers and patients need to collaborate to enable fast recovery and good outcomes. Good innovation and policy to reduce this is essential for the outcome of treatment of Covid-19 patients.